(MedPage Today) — For high bleeding risk patients, rationale for BMS continues to shrink
via TCT: Advantage of Novel DES Over BMS Grows With Time
by
from Blogger http://ift.tt/2f2MaKQ
via https://www.youtube.com/channel/UC6RqJb8h-y4xS4g-vzofotQ/videos
Advertisements